Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
NCL International Logistics Public Company Limited, with its affiliated companies, delivers a comprehensive suite of logistics services crucial for global commerce, encompassing international cargo forwarding, customs brokerage, internal transportation, and integrated multimodal solutions for both incoming and outgoing goods. The enterprise's operations are divided into four primary divisions: land transport, freight management, non-vessel operating common carrier (NVOCC) activities, and the manufacturing and supply of dialysis products. Their offerings specifically include ocean shipping, air freight, and domestic road transport via trucks. Beyond logistics, NCL also produces and markets specialized dialysis solutions for patients using artificial kidneys, and distributes vital medical equipment necessary for hemodialysis treatment. The company, which originated in 1994, maintains its corporate headquarters in Bangkok, Thailand.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.